Cerenome (PSTV) Non-Current Debt (2010 - 2022)
Plus Therapeutics (PSTV) posted quarterly Non-Current Debt of $3.8 million for Q4 2022, down 24.36% year-over-year from $5.0 million in Q4 2021, and down 7.84% quarter-over-quarter from $4.1 million in Q3 2022.
Cerenome (PSTV) Non-Current Debt (2010 - 2022) Analysis & Trends
Plus Therapeutics (PSTV) has reported Non-Current Debt for 10 consecutive years, with $3.8 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Non-Current Debt fell 24.36% year-over-year to $3.8 million; the TTM figure through Dec 2022 stood at $3.8 million (down 24.36% YoY), while the FY2022 annual figure was $3.8 million, down 24.36% from the prior year.
- Non-Current Debt slipped to $3.8 million in Q4 2022 per PSTV's latest filing, from $4.1 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $5.0 million in Q4 2021 and bottomed at $3.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 4.11 Mn |
| Jun 30, 2022 | 4.42 Mn |
| Mar 31, 2022 | 4.72 Mn |
| Dec 31, 2021 | 5.01 Mn |
| Jun 30, 2017 | 7.77 Mn |
| Mar 31, 2017 | 9.40 Mn |
| Dec 31, 2016 | 11.01 Mn |
| Sep 30, 2016 | 12.13 Mn |
| Jun 30, 2016 | 13.66 Mn |
| Mar 31, 2016 | 15.20 Mn |
| Dec 31, 2015 | 16.68 Mn |
| Sep 30, 2015 | 14.98 Mn |
| Jun 30, 2015 | 16.18 Mn |
| Mar 31, 2015 | 15.68 Mn |
| Dec 31, 2014 | 18.04 Mn |
| Sep 30, 2014 | 20.33 Mn |
| Jun 30, 2014 | 19.50 Mn |
| Mar 31, 2014 | 21.33 Mn |
| Dec 31, 2013 | 23.10 Mn |